Fluorescence induced by aminolevulinic acid and methyl aminolevulinate on normal skin

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 4, 2007, Pages 224-229

  Lesar, Andrea ^a   Padgett, Miles ^b   O'Dwyer, Martin ^b   Ferguson, James ^a   Moseley, Harry ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

5 ALA; 5 Aminolevulinic acid; Fluorescence; Methyl aminolevulinate; PpIX; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; METXIV; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLUORESCENCE; FOREARM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN; SPECTROSCOPY; TREATMENT DURATION;

EID: 36349011298     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2007.09.002     Document Type: Article

References (29)

1. Sieroń A., Kawczyk-Krupka A., Adamek M., et al. Photodynamic diagnosis (PDD) and photodynamic therapy (PDT) in dermatology: "How we do it". Photodiag Photodyn Ther 3 (2006) 132-133
2. Ibbotson S.H. How we treat a superficial basal cell carcinoma with topical photodynamic therapy in Dundee. Photodiag Photodyn Ther 3 (2006) 128-131
3. Moseley H., Ibbotson S., Woods J., Brancaleon L., et al. Clinical and research applications of photodynamic therapy in dermatology: Experience of the Scottish PDT Centre. Lasers Surg Med 38 (2006) 403-416
4. De Rosa F.S., Tedesco A.C., Lopez R.F., et al. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J Control Release 89 (2003) 261-269
5. Gerscher S., Connelly J.P., Griffiths J., et al. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolised from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem Photobiol 72 (2000) 569-574
6. Gerscher S., Connelly J.P., Beijersbergen Van Henegouwen G.M., Macrobert A.J., Watt P., and Rhodes L.E. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolevulinic acid and 5-aminolevulinic acid-n-pentylester. Br J Dermatol 144 (2001) 983-990
7. Ackermann G., Abels C., Baumler W., et al. Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo. J Photochem Photobiol B 47 (1998) 121-128
8. Gaullier J.M., Berg K., Peng Q., et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 57 (1997) 1481-1486
9. Brunner H., Hausmann F., and Knuechel R. New 5-aminolevulinic acid esters-efficient protoporphyrin precursors for photodetection and photodynamic therapy. Photochem Photobiol 78 (2003) 481-486
10. Zenzen V., and Zankl H. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo. Cancer Lett 202 (2003) 35-42
11. van den Akker J.T., Iani V., Star W.M., Sterenborg H.J., and Moan J. Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions. Photochem Photobiol 75 (2002) 172-177
12. Ogasawara T., Miyoshi N., Fukuda M., et al. Fluorescent analysis of 5-aminolevulinic acid-induced protoporphyrin-IX in mouse transplanted tumour tissues. Int Congress Ser 1248 (2003) 405-408
13. Cairnduff F., Stringer M.R., Hudson E.J., Ash D.V., and Brown S.B. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69 (1994) 605-608
14. Morton C.A., Whitehurst C., Moseley H., McColl J.H., Moore J.V., and MacKie R.M. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 135 (1996) 766-771
15. Morton C.A., Whitehurst C., Moore J.V., and MacKie R.M. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 143 (2000) 767-772
16. Donnelly R.F., Juzenas P., McCarron P.A., Ma L.-W., Woolfson A.D., and Moan J. Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo. Photodiag Photodyn Ther 3 (2006) 190-201
17. Juzenas P., Sharfaei S., Moan J., and Bissonnette R. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester. J Photochem Photobiol B 67 (2002) 11-17
18. ® CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: a fluorescence and extraction study. Photodiag Photodyn Ther (2006) 27-33
19. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124 (1988) 869-871
20. Nadeau V., Hamdan K., Hewett J., et al. Endoscopic fluorescence imaging and point spectroscopy system for the detection of gastro-intestinal cancers. J Modern Opt 49 (2002) 731-741
21. Nadeau V., O'Dwyer M., Hamdan K., Tait I., and Padgett M. In vivo measurement of 5-aminolevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities. Photodermatol Photoimmunol Photomed 20 (2004) 170-174
22. O'Dwyer M., Nadeau V., and Padgett M. A spectroscopic tool based on an interference filter and birefringent prisms: demonstration of detection of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. J Phys D: Appl Phys 36 (2003) 1703-1706
23. Ibbotson S.H., Jong C., Lesar A., et al. Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo. Photodermatol Photoimmunol Photomed 22 (2006) 105-110
24. Kennedy J.C., and Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14 (1992) 275-292
25. Van den Akker J.T., Iani V., Star W.M., Sterenborg H.J., and Moan J. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72 (2000) 681-689
26. Washbrook R., and Riley P.A. Comparison of delta-aminolevulinic acid and its methyl ester as an inducer of porphyrin synthesis in cultured cells. Br J Cancer 75 (1997) 1417-142
27. Kloek J., Akkermans W., and Beijersbergen Van Henegouwen G.M. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 67 (1998) 150-154
28. Fritsch C., Lang K., Neuse W., Ruzicka T., and Lehmann P. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 11 (1998) 358-373
29. Di Venosa G.M., Fukuda H., Batlle A., Macrobert A.J., and Casas A. Photodynamic therapy: regulation of porphyrin synthesis and hydrolysis from ALA esters. Photochem Photobiol 83 (2006) 129-136